{"id":1482,"date":"2026-01-25T15:18:49","date_gmt":"2026-01-25T21:18:49","guid":{"rendered":"https:\/\/zogen.local\/?p=1482"},"modified":"2026-01-25T15:18:49","modified_gmt":"2026-01-25T21:18:49","slug":"lymphoma-how-genomic-testing-can-transform-treatment","status":"publish","type":"post","link":"https:\/\/zogen.mx\/en\/linfoma-como-las-pruebas-genomicas-pueden-transformar-el-tratamiento\/","title":{"rendered":"Lymphoma: How Genomic Testing Can Transform Treatment"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n

Introduction:<\/strong><\/h3>\n\n\n\n

Lymphoma: How Genomic Testing Can Transform Treatment <\/p>\n\n\n\n

Lymphoma is one of the most common cancers of the lymphatic system and can affect people of any age. Fortunately, advances in cancer medicine have allowed treatments to become increasingly personalized and specific. One of the key tools for this personalization is the use of\u00a0genomic tests<\/strong>. These tests allow oncologists to understand the genetic characteristics of lymphoma and, in this way, design a more appropriate and effective treatment.<\/p>\n\n\n\n

In this article, we will explore how genomic testing can make a difference in the treatment of lymphoma, and how its implementation in personalized medicine is changing the outlook for thousands of patients.<\/p>\n\n\n\n

\n\n\n\n

What is lymphoma?<\/strong><\/h3>\n\n\n\n

Lymphoma is a type of cancer that originates in the cells of the lymphatic system, which is an essential part of the immune system. There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma, the latter being more common and encompassing a wide variety of subtypes.<\/p>\n\n\n\n

Because this disease can present in various forms and with different degrees of aggressiveness, it is essential to be able to identify the particular characteristics of each case. This is where genomic testing plays a crucial role.<\/p>\n\n\n\n

\n\n\n\n

Genomic testing in lymphoma treatment<\/strong><\/h3>\n\n\n\n

Genomic testing uses advanced tools to analyze the DNA of cancer cells. By identifying mutations or genetic alterations, doctors can design much more specific and effective treatments. Genomic testing in lymphoma provides information about:<\/p>\n\n\n\n

    \n
  1. The type of lymphoma<\/strong>Not all lymphomas are the same. Genetics can determine whether a lymphoma is more or less aggressive and how it will behave.<\/li>\n\n\n\n
  2. The response to treatment<\/strong>By understanding the genetic basis of lymphoma, it is possible to predict which therapies will work best, whether chemotherapy, immunotherapy, or targeted treatments.<\/li>\n\n\n\n
  3. Patient prognosis<\/strong>The genetic information obtained allows for more accurate estimates of disease progression and treatment response rates.<\/li>\n<\/ol>\n\n\n\n

    <\/p>\n\n\n\n

    Types of lymphoma: A cancer with many faces<\/strong><\/h3>\n\n\n\n

    There are two main categories of lymphoma:<\/p>\n\n\n\n

      \n
    1. Hodgkin lymphoma (HL)<\/strong>It is less common and is characterized by the presence of Reed-Sternberg cells, a specific type of cancerous cell. This type of lymphoma generally has a high cure rate if diagnosed and treated early.<\/li>\n\n\n\n
    2. Non-Hodgkin lymphoma (NHL)<\/strong>It represents a broader category that includes several subtypes, some more aggressive than others. Within non-Hodgkin lymphomas, there are many subtypes that can behave very differently and, therefore, require specific treatments.<\/li>\n<\/ol>\n\n\n\n

      <\/p>\n\n\n\n

      Subtypes of non-Hodgkin lymphoma (NHL):<\/strong><\/h4>\n\n\n\n